Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
Journal for Immunotherapy of Cancer
|
July 18, 2020
Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
Kenji Fujiwara, May Tun Saung, Hao Jing, et al.
Cell Discovery
|
February 5, 2026
Integrating single-nucleus barcoding with spatial transcriptomics via Stamp-seq to reveal immunotherapy response-enhancing functional modules in NSCLC
Yitong Pan, Huan Yan, Jinhuan Han, et al.
Journal of Medical Virology
|
November 24, 2022
Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID-19 survivors
Chen Jia, Zhiguo Zhou, Wenjing Pan, et al.
Journal of Hematology & Oncology
|
March 29, 2022
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
Tao Xia, Keyu Li, Nan Niu, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming
Noelle R J Thielman, Vanessa Funes, Sanjana Davuluri, et al.
Hepatology (Baltimore, Md.)
|
August 18, 2016
N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway
Jiabei Wang, Changming Xie, Shangha Pan, et al.
Science Advances
|
October 16, 2024
Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming
Noelle R J Thielman, Vanessa Funes, Sanjana Davuluri, et al.
The Journal of Experimental Medicine
|
April 11, 2022
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma
Jianxin Wang, May Tun Saung, Keyu Li, et al.
Journal of Hematology & Oncology
|
August 7, 2024
Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration
Keyu Li, Junke Wang, Rui Zhang, et al.
Gastroenterology
|
June 19, 2022
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy
Alex B Blair, Jianxin Wang, John Davelaar, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
Journal for Immunotherapy of Cancer
|
July 18, 2020
Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer
Kenji Fujiwara, May Tun Saung, Hao Jing, et al.
Cell Discovery
|
February 5, 2026
Integrating single-nucleus barcoding with spatial transcriptomics via Stamp-seq to reveal immunotherapy response-enhancing functional modules in NSCLC
Yitong Pan, Huan Yan, Jinhuan Han, et al.
Journal of Medical Virology
|
November 24, 2022
Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID-19 survivors
Chen Jia, Zhiguo Zhou, Wenjing Pan, et al.
Journal of Hematology & Oncology
|
March 29, 2022
Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
Tao Xia, Keyu Li, Nan Niu, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Tumor- and Nerve-Derived Axon Guidance Molecule Promotes Pancreatic Ductal Adenocarcinoma Progression and Metastasis through Macrophage Reprogramming
Noelle R J Thielman, Vanessa Funes, Sanjana Davuluri, et al.
Hepatology (Baltimore, Md.)
|
August 18, 2016
N-myc downstream-regulated gene 2 inhibits human cholangiocarcinoma progression and is regulated by leukemia inhibitory factor/MicroRNA-181c negative feedback pathway
Jiabei Wang, Changming Xie, Shangha Pan, et al.
Science Advances
|
October 16, 2024
Semaphorin 3D promotes pancreatic ductal adenocarcinoma progression and metastasis through macrophage reprogramming
Noelle R J Thielman, Vanessa Funes, Sanjana Davuluri, et al.
The Journal of Experimental Medicine
|
April 11, 2022
CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma
Jianxin Wang, May Tun Saung, Keyu Li, et al.
Journal of Hematology & Oncology
|
August 7, 2024
Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration
Keyu Li, Junke Wang, Rui Zhang, et al.
Gastroenterology
|
June 19, 2022
Dual Stromal Targeting Sensitizes Pancreatic Adenocarcinoma for Anti-Programmed Cell Death Protein 1 Therapy
Alex B Blair, Jianxin Wang, John Davelaar, et al.
Page
of 10